News

DoH to change GP contract to cut correction factors

18-Jul-08

Dr Laurence Buckman
The DoH will change the contract to allow correction factors to be cut legally, the GPC announced yesterday.

The DoH is required to launch a consultation before it unilaterally changes the contract, which the BMA is responding to.

GPC negotiators say the DoH has acknowledged that the Doctors’ and Dentists’ Review Body’s recommendation to cut correction factors is illegal, so is now consulting on how to implement it legally.

The cuts to correction factors mean despite a 2.7 per cent increase to the global sum, all practices on MPIG will effectively receive nothing.

GPC deputy chairman Dr Richard Vautrey said this would mean changing the statement of financial entitlement (SFE) annex of the contract.

‘We will be challenging this in our response which is currently in the hands of our lawyers,’ he said.

GPC chairman Dr Laurence Buckman said after the consultation, a set of instructions will be sent to parliament and practices and legislative changes will be made.

The GPC’s only victory has been that changes will not be back-dated to April, but will come into force when the consultation concludes.

A DoH spokesman said the consultation would close in September. A decision will be taken then based on the comment received. 

tom.ireland@haymarket.com

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Jobs

 

Job of the Week

Latest Clinical Articles

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Sjogren's syndrome

Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more

Show all clinical articles

MIMS Product News

New drug - Intelence

Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more

New drug - Doribax

Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more

Ebixa dosing made easier

Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more